Bharat Biotech and Bilthoven Biologicals B.V. Announce Collaboration to Produce and Supply Oral Polio Vaccines

Bharat Biotech, a global leader in vaccine and biotherapeutic innovation, and also the largest manufacturer of oral polio vaccines, and Bilthoven Biologicals B.V., (BBio), a wholly owned subsidiary of Serum Institute of India Private Limited, based in the Netherlands, announced a collaboration today, to further strengthen the production and supply security of Oral Polio Vaccines (OPV).

A requisite Agreement has been signed between BBIL and BBio wherein BBIL will procure drug substances for the production of oral polio vaccines to be supplied within India and globally.

Join PSU Connect on WhatsApp now for quick updates! Click here

Read Also : IndianOil Wins Big at FICCI Indian Sports Awards 2024 for Championing Sports Development

Through this collaboration, BBIL and BBio will jointly obtain the regulatory approvals and licenses required to commercially manufacture OPVs in India for global supplies from drug substances manufactured in the Netherlands at Bilthoven Biologicals.

 

Read Also : NTPC Talcher Kaniha Shines with Prestigious Platinum Award